Sitryx Therapeutics Ltd, a biopharmaceutical company pioneering the field of immunometabolism, announced the appointment of Dr. Ravi M. Rao as its Chief Medical Officer. Dr. Rao is a rheumatologist and pharmaceutical physician with over fifteen years of leadership experience in both large and mid-sized pharmaceutical and biotechnology companies with a wide range of therapeutic area expertise including…